Christie Mensch
Psychiatry · Mission, KSNPI 1164524898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,542 and has fallen 98.7% since, to $20 in 2022.
Across 189 payments — averaging $12.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$361
- AbbVie$330
- Neurocrine Biosciences, Inc.$307
- Otsuka America Pharmaceutical, Inc.$296
- Sunovion Pharmaceuticals Inc.$286
- Vanda Pharmaceuticals Inc.$235
- plus $590 from 9 others
What the payments were for
- Food & beverage$2,395100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $361 |
| AbbVie(2 entities) | 31 | $330 |
| Neurocrine Biosciences, Inc. | 16 | $307 |
| Otsuka America Pharmaceutical, Inc. | 23 | $296 |
| Sunovion Pharmaceuticals Inc. | 24 | $286 |
| Vanda Pharmaceuticals Inc. | 21 | $235 |
| Lundbeck LLC | 24 | $231 |
| Alkermes, Inc. | 9 | $156 |
| Avanir Pharmaceuticals, Inc. | 4 | $75 |
| Indivior Inc. | 4 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$2,407 in reported general payments places this provider in the 80th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Mission
- David WichmanManhattan$613K
- Kevin MaysLeawood$548K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
- Sasha HamdaniOverland Park$104K
- Christine GlennKansas City$58K
- Heidi OgdenWichita$55K
- Mark RomereimHays$41K
- Patrick StangGreat Bend$28K
- Ralph BharatiWichita$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.